The U.S. drug policy landscape : insights and opportunities for improving the view / Beau Kilmer [and others].
Contributor(s): Kilmer, Beau | Rand Corporation | RAND Drug Policy Research Center.Material type: BookSeries: Occasional paper (Rand Corporation): OP-393.Publisher: Santa Monica, CA : Rand Corporation, 2012Description: 1 online resource (xiv, 51 pages) : charts.Content type: text Media type: computer Carrier type: online resourceISBN: 0833077317; 0833077333; 9780833077318; 9780833077332.Other title: United States drug policy landscape | US drug policy landscape.Subject(s): Drug abuse -- Government policy -- United States | Drug control -- United States | Anthropology, Education, Sociology and Social Phenomena | Delivery of Health Care | Drug and Narcotic Control | Health Care Economics and Organizations | Health Services Administration | Legislation as Topic | Legislation, Drug | Organization and Administration | Pharmacy Administration | Policy | Public Policy | Social Control Policies | Social Control, Formal | Social Sciences | Sociology | BUSINESS & ECONOMICS -- Infrastructure | Drug abuse -- Government policy | Drug control | POLITICAL SCIENCE -- Public Policy -- Social Policy | SOCIAL SCIENCE -- General | Social Sciences | Social Welfare & Social Work | Substance Abuse | United StatesGenre/Form: Electronic books.Additional physical formats: Print version:: U.S. Drug Policy Landscape : Insights and Opportunities for Improving the View.DDC classification: 363.450973 Online resources: Digital version
|Item type||Current location||Call number||URL||Status||Notes||Date due||Barcode|
|E-books||http://www.jstor.org/stable/10.7249/j.ctt1q60vs||Not for loan||Only accessible on campus.|
Title from PDF title screen (viewed on Sept. 14, 2012).
Includes bibliographical references (pages 41-51).
Introduction -- The drug policy landscape in the United States -- Efficacy of U.S. drug policies and programs -- The drug policy research funding landscape -- Opportunities to influence the drug policy field -- Concluding thoughts.
Discussions about reducing the harms associated with drug use and antidrug policies are often politicized, infused with questionable data, and unproductive. This paper provides a nonpartisan primer that should be of interest to those who are new to the field of drug policy, as well as those who have been working in the trenches. It begins with an overview of problems and policies related to illegal drugs in the United States, including the nonmedical use of prescription drugs. It then discusses the efficacy of U.S. drug policies and programs, including long-standing issues that deserve additional attention. Next, the paper lists the major funders of research and analysis in the area and describes their priorities. By highlighting the issues that receive most of the funding, this discussion identifies where gaps remain. Comparing these needs, old and new, to the current funding patterns suggests eight opportunities to improve understanding of drug problems and drug policies in the United States: (1) sponsor young scholars and strengthen the infrastructure of the field, (2) accelerate the diffusion of good ideas and reliable information to decision-makers, (3) replicate and evaluate cutting-edge programs in an expedited fashion, (4) support nonpartisan research on marijuana policy, (5) investigate ways to reduce drug-related violence in Mexico and Central America, (6) improve understanding of the markets for diverted pharmaceuticals, (7) help build and sustain comprehensive community prevention efforts, and (8) develop more sensible sentencing policies that reduce the excessive levels of incarceration for drug offenses and address the extreme racial disparities. The document offers some specific suggestions for researchers and potential research funders in each of the eight areas.
"This research was sponsored by the John D. and Catherine T. MacArthur Foundation ..."
JSTOR Books at JSTOR Open Access